What is a normal gallbladder ejection fraction (GEF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A normal gallbladder ejection fraction is defined as ≥38%. This definition is based on the recommendations of an interdisciplinary panel that suggested the use of a standardized protocol for cholecystokinin-cholescintigraphy (CCK-CS) in adults, as described in a study published in the Clinical Gastroenterology and Hepatology journal in 2011 1.

Key Points to Consider

  • The panel recommended a CCK-CS protocol involving infusion of 0.02 g/kg of sincalide over 60 minutes to determine the gallbladder ejection fraction.
  • The primary indication for CCK-CS is in the diagnosis of functional gallbladder disease in well-selected patients.
  • A gallbladder ejection fraction below the normal threshold may indicate gallbladder dysfunction, such as chronic cholecystitis or biliary dyskinesia.

Clinical Application

The measurement of gallbladder ejection fraction is crucial in clinical practice, particularly for patients presenting with biliary-type symptoms without evidence of gallstones on ultrasound.

  • It helps clinicians assess gallbladder function and determine if symptoms are related to poor gallbladder function.
  • This information is valuable when considering cholecystectomy for patients with suspected functional gallbladder disorders.

Evidence-Based Recommendation

The normal gallbladder ejection fraction of ≥38% should be used as a reference value in clinical practice, based on the most recent and highest quality evidence available 1.

From the Research

Normal Gallbladder Ejection Fraction

  • A normal gallbladder ejection fraction (GBEF) is considered to be > or =35% with a 3-min infusion and > or =50% with a 10-min infusion of cholecystokinin-8 (CCK-8) 2.
  • The mean GBEF value was reproducible between two sequential studies in the control group, with values of 66.0% +/- 20.5% and 73.9% +/- 17.7% 2.
  • A study of 40 normal volunteers found that the maximum mean gallbladder ejection fraction occurred 15 minutes after CCK infusion and was 74.5% +/- 1.9% (mean +/- SEM), with a normal GBEF defined as greater than 40% (mean -3SD) 3.

Factors Affecting Gallbladder Ejection Fraction

  • Opioid intake before the study can affect GBEF values, and exclusion of opioid intake is critical before attributing a low GBEF value to an irreversible GB motor dysfunction 2.
  • CCK-induced cystic duct spasm is the etiology for low GBEF in both chronic acalculous cholecystitis (CAC) and chronic calculous cholecystitis (CCC) 2.
  • The severity of GBEF reduction in CAC increases with time, with a mean reduction of 7.2% +/- 8.1% within 12 months, 16.1% +/- 14.9% in 13-47 months, and 23.5% +/- 21.3% in 48-168 months 2.

Clinical Implications

  • A low GBEF value is associated with biliary dyskinesia, a functional gallbladder disorder characterized by altered gallbladder motility 4, 5.
  • Cholecystectomy can alleviate symptoms in patients with biliary dyskinesia and a low GBEF value, with symptom resolution reported in 84% of patients in one study 5.
  • However, the diagnostic value of cholescintigraphy in patients with acalculous right upper quadrant pain is low, and a low GBEF does not predict clinical outcome or histologic features of chronic cholecystitis 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.